Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 2,399.36 | 1,671.24 | 1,974.60 | 1,691.61 |
Depreciation/ Depletion | 398.25 | 325.92 | 166.62 | 118.97 |
Non- Cash Items | -186.05 | -27.49 | -135.81 | -124.63 |
Changesin Working Capital | -459.12 | -156.37 | -1,085.63 | -548.71 |
Cashfrom Operating Activities | 2,152.45 | 1,813.30 | 919.78 | 1,137.24 |
Capital Expenditures | -389.21 | -832.07 | -2,345.52 | -312.32 |
Other Investing Cash Flow Items Total | -1,692.48 | -222.06 | 976.38 | -909.90 |
Cashfrom Investing Activities | -2,081.69 | -1,054.13 | -1,369.14 | -1,222.21 |
Financing Cash Flow Items | -26.17 | -41.93 | -17.79 | -117.16 |
Issuance( Retirement)of Debt Net | 31.44 | -697.80 | 622.41 | 109.35 |
Cashfrom Financing Activities | 5.27 | -739.73 | 604.62 | -7.81 |
Foreign Exchange Effects | 1.17 | 2.32 | 0.48 | 0.38 |
Net Changein Cash | 77.19 | 21.76 | 155.73 | -92.40 |
Cash Interest Paid | 26.17 | 41.93 | 17.79 | 17.10 |
Cash Taxes Paid | 479.53 | 323.10 | 499.51 | 454.08 |
Mankind Pharma Dividend Mankind Pharma Bonus Mankind Pharma News Mankind Pharma AGM Mankind Pharma Rights Mankind Pharma Splits Mankind Pharma Board Meetings Mankind Pharma Key Metrics Mankind Pharma Shareholdings Mankind Pharma Profit Loss Mankind Pharma Balance Sheet Mankind Pharma Q1 Results Mankind Pharma Q2 Results Mankind Pharma Q3 Results Mankind Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks